Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries American Cryostem Corp (OP: CRYO ) N/A UNCHANGED Last Price Updated: 3:04 PM EDT, Apr 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about American Cryostem Corp American CryoStem Announces Patient Treatment Status for its Phase I Clinical Trial for Post-Concussion Syndrome (PCS) March 04, 2022 EATONTOWN, NJ / ACCESSWIRE / March 4, 2022 / American CryoStem Corporation (OTC PINK:CRYO) a clinical stage biotechnology company, global licensor, and a pioneer in autologous cellular processing and... From American CryoStem Corporation Via AccessWire American CryoStem Announces Completion of Patient Recruitment for its Post-Concussion Syndrome (PCS) ATCELL(TM) Phase I Clinical Trial December 22, 2021 EATONTOWN, NJ / ACCESSWIRE / December 22, 2021 / American CryoStem Corporation (OTC PINK:CRYO) a clinical-stage biotechnology company, global licensor, and a pioneer in autologous cellular processing... From American CryoStem Corporation Via AccessWire American CryoStem Completes Clinical Protocol Design for Long COVID Study November 30, 2021 EATONTOWN, NJ / ACCESSWIRE / November 30, 2021 / American CryoStem Corporation (OTC PINK:CRYO), a leading clinical-stage biotechnology developer of adipose-derived stem cell therapies today announced... From American CryoStem Corporation Via AccessWire Topics Intellectual Property Exposures COVID-19 Intellectual Property Product Safety American CryoStem Announces the Addition of John Schwartz, PhD to Its Advisory Board November 23, 2021 EATONTOWN, NJ / ACCESSWIRE / November 23, 2021 / American CryoStem Corporation (OTC PINK:CRYO), a leading clinical-stage biotechnology developer of adipose tissue-based cellular technologies for... From American CryoStem Corporation Via AccessWire Topics Intellectual Property Exposures Intellectual Property Product Safety American CryoStem to Study New Standardized Treatment Protocols for Wound Healing November 16, 2021 EATONTOWN, NJ / ACCESSWIRE / November 16, 2021 / American CryoStem Corporation (OTC PINK:CRYO), a clinical stage biotechnology company, global licensor and a pioneer in autologous cellular processing... From American CryoStem Corporation Via AccessWire Topics Intellectual Property Exposures Intellectual Property Product Safety American CryoStem Enters into an Agreement to Exchange Shares held by ACS Global, Inc November 12, 2021 EATONTOWN, NJ / ACCESSWIRE / November 12, 2021 / American CryoStem Corporation (OTC PINK:CRYO), a leading strategic cellular application developer, global licensor of patented adipose tissue-based... From American CryoStem Corporation Via AccessWire Topics Intellectual Property Exposures Intellectual Property Product Safety American CryoStem Executes LOI with Advanced Regenerative Associates to Conduct Wound Healing Clinical Study May 06, 2021 EATONTOWN, NJ / ACCESSWIRE / May 6, 2021 / American CryoStem Corporation (OTC PINK:CRYO) a clinical-stage biotechnology company, global licensor, and a pioneer in autologous cellular processing and... From American CryoStem Corporation Via AccessWire Exposures Product Safety Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.